文献速递肝病

综述:戊型肝炎——病毒学、流行病学、临床表现与治疗的简明综述

Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.
PubMed 文献 · Aliment Pharmacol Ther · 2017-04-27

戊型肝炎病毒是发展中国家急性黄疸型肝炎和急性肝衰竭的主要原因之一,近十年发达国家本土感染日益受到认识。慢性戊型肝炎自2008年被认识,在移植受者中可导致肝硬化和器官衰竭。利巴韦林用于治疗慢性戊型肝炎,但已有治疗失败的报道,需要新疗法。

要点

  • 发达国家本土戊型肝炎感染日益增多,主要与基因3型相关。
  • 慢性戊型肝炎自2008年被认识,移植受者中可导致肝硬化和器官衰竭。
  • 利巴韦林用于治疗慢性戊型肝炎,但已有治疗失败的报道,需要新疗法。

核心结论

  • 本土戊型肝炎感染是临床问题,负担日益增加。
  • 未来工作应侧重于提高发达国家对戊型肝炎感染的认识,强调临床医生应保持较低的戊型肝炎检测门槛,尤其是在免疫抑制患者中。
  • 有慢性戊型肝炎感染潜在风险的患者也必须接受教育并获得关于预防感染的建议。

研究设计与样本

  • 综述:检索PubMed英文文献,关键词包括「hepatitis E」「viral hepatitis」「autochthonous infection」「antiviral therapy」「liver transplantation」「acute」「chronic」「HEV」「genotype」「transmission」「food-borne」「transfusion」,并从文章参考文献列表中识别其他相关出版物。

主要发现

  • 西方国家本土戊型肝炎感染日益受到认识,主要与基因3型相关。
  • 慢性戊型肝炎感染自2008年被认识,在移植受者中可导致肝硬化和器官衰竭。
  • 传播方式包括食源性传播、血液制品输注和实体器官移植。
  • 利巴韦林治疗用于慢性戊型肝炎感染患者,但已有利巴韦林治疗失败的报道,需要新疗法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis E virus (HEV) is a leading cause of acute icteric hepatitis and acute liver failure in the developing world. During the last decade, there has been increasing recognition of autochthonous (locally acquired) HEV infection in developed countries. Chronic HEV infection is now recognised, and in transplant recipients this may lead to cirrhosis and organ failure. AIM: To detail current understanding of the molecular biology of HEV, diagnostic and therapeutic strategies and propose future directions for basic science and clinical research. METHODS: PubMed was searched for English language articles using the key words "hepatitis E", "viral hepatitis", "autochthonous infection", "antiviral therapy", "liver transplantation", "acute", "chronic", "HEV", "genotype", "transmission" "food-borne", "transfusion". Additional relevant publications were identified from article reference lists. RESULTS: There has been increasing recognition of autochthonous HEV infection in Western countries, mainly associated with genotype 3. Chronic HEV infection has been recognised since 2008, and in transplant recipients this may lead to cirrhosis and organ failure. Modes of transmission include food-borne transmission, transfusion of blood products and solid organ transplantation. Ribavirin therapy is used to treat patients with chronic HEV infection, but new therapies are required as there have been reports of treatment failure with ribavirin. CONCLUSIONS: Autochthonous HEV infection is a clinical issue with increasing burden. Future work should focus on increasing awareness of HEV infection in the developed world, emphasising the need for clinicians to have a low threshold for HEV testing, particularly in immunosuppressed patients. Patients at potential risk of chronic HEV infection must also be educated and given advice regarding prevention of infection.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Donnelly MC, Scobie L, Crossan CL, et al. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther. 2017. PMID: 28449246. doi:10.1111/apt.14109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。